1	Western	_	NN	_	_	2	NMOD	_	_
2	blotting	_	NN	_	_	0	ROOT	_	_
3	.	_	.	_	_	2	P	_	_
		
1	For	_	IN	_	_	14	VMOD	_	_
2	human	_	JJ	_	_	3	NMOD	_	_
3	RUNX1	_	NN	_	_	1	PMOD	_	_
4	and	_	CC	_	_	3	COORD	_	_
5	RUNX3	_	NN	_	_	6	NMOD	_	_
6	analysis	_	NN	_	_	4	CONJ	_	_
7	on	_	IN	_	_	3	NMOD	_	_
8	the	_	DT	_	_	10	NMOD	_	_
9	protein	_	NN	_	_	10	NMOD	_	_
10	level	_	NN	_	_	7	PMOD	_	_
11	,	_	,	_	_	14	P	_	_
12	106	_	CD	_	_	13	NMOD	_	_
13	cells	_	NNS	_	_	14	VMOD	_	_
14	were	_	VBD	_	_	0	ROOT	_	_
15	lysed	_	VBN	_	_	14	VC	_	_
16	and	_	CC	_	_	15	COORD	_	_
17	loaded	_	VBN	_	_	16	CONJ	_	_
18	next	_	JJ	_	_	17	VMOD	_	_
19	to	_	TO	_	_	18	AMOD	_	_
20	a	_	DT	_	_	22	NMOD	_	_
21	protein-mass	_	NN	_	_	22	NMOD	_	_
22	ladder	_	NN	_	_	19	PMOD	_	_
23	(	_	(	_	_	24	P	_	_
24	Invitrogen	_	NNP	_	_	18	PRN	_	_
25	)	_	)	_	_	24	P	_	_
26	on	_	IN	_	_	17	VMOD	_	_
27	a	_	DT	_	_	32	NMOD	_	_
28	NuPAGE	_	JJ	_	_	32	NMOD	_	_
29	4-12	_	CD	_	_	30	AMOD	_	_
30	%	_	NN	_	_	32	NMOD	_	_
31	Bis-Tris	_	NN	_	_	32	NMOD	_	_
32	gel	_	NN	_	_	26	PMOD	_	_
33	(	_	(	_	_	34	P	_	_
34	Invitrogen	_	NNP	_	_	32	PRN	_	_
35	)	_	)	_	_	34	P	_	_
36	.	_	.	_	_	14	P	_	_
		
1	The	_	DT	_	_	2	NMOD	_	_
2	proteins	_	NNS	_	_	3	VMOD	_	_
3	were	_	VBD	_	_	0	ROOT	_	_
4	electroblotted	_	VBN	_	_	3	VC	_	_
5	onto	_	IN	_	_	4	VMOD	_	_
6	a	_	DT	_	_	8	NMOD	_	_
7	PVDF	_	NN	_	_	8	NMOD	_	_
8	membrane	_	NN	_	_	5	PMOD	_	_
9	(	_	(	_	_	11	P	_	_
10	GE	_	NN	_	_	11	NMOD	_	_
11	Healthcare	_	NN	_	_	8	PRN	_	_
12	)	_	)	_	_	11	P	_	_
13	.	_	.	_	_	3	P	_	_
		
1	Unspecific	_	JJ	_	_	2	NMOD	_	_
2	binding	_	NN	_	_	3	VMOD	_	_
3	was	_	VBD	_	_	0	ROOT	_	_
4	blocked	_	VBN	_	_	3	VC	_	_
5	with	_	IN	_	_	4	VMOD	_	_
6	3	_	CD	_	_	7	AMOD	_	_
7	%	_	NN	_	_	8	NMOD	_	_
8	milk	_	NN	_	_	5	PMOD	_	_
9	in	_	IN	_	_	8	NMOD	_	_
10	TBS	_	NN	_	_	11	NMOD	_	_
11	Tween	_	NNP	_	_	9	PMOD	_	_
12	,	_	,	_	_	3	P	_	_
13	and	_	CC	_	_	3	COORD	_	_
14	the	_	DT	_	_	15	NMOD	_	_
15	membranes	_	NNS	_	_	16	VMOD	_	_
16	were	_	VBD	_	_	13	CONJ	_	_
17	subsequently	_	RB	_	_	16	VMOD	_	_
18	incubated	_	VBN	_	_	16	VC	_	_
19	with	_	IN	_	_	18	VMOD	_	_
20	a	_	DT	_	_	22	NMOD	_	_
21	1:1,000	_	NN	_	_	22	NMOD	_	_
22	dilution	_	NN	_	_	19	PMOD	_	_
23	of	_	IN	_	_	22	NMOD	_	_
24	rabbit	_	NN	_	_	25	NMOD	_	_
25	anti-RUNX1	_	NN	_	_	23	PMOD	_	_
26	(	_	(	_	_	27	P	_	_
27	ab11903	_	CD	_	_	25	PRN	_	_
28	;	_	:	_	_	27	P	_	_
29	Abcam	_	NNP	_	_	27	APPO	_	_
30	)	_	)	_	_	27	P	_	_
31	or	_	CC	_	_	25	COORD	_	_
32	1:200	_	NN	_	_	33	NMOD	_	_
33	dilution	_	NN	_	_	31	CONJ	_	_
34	of	_	IN	_	_	22	NMOD	_	_
35	rabbit	_	NN	_	_	36	NMOD	_	_
36	anti-RUNX3	_	NN	_	_	34	PMOD	_	_
37	(	_	(	_	_	38	P	_	_
38	H-50	_	NN	_	_	18	PRN	_	_
39	;	_	:	_	_	38	P	_	_
40	Santa	_	NNP	_	_	41	NAME	_	_
41	Cruz	_	NNP	_	_	38	COORD	_	_
42	Biotechnology	_	NN	_	_	41	APPO	_	_
43	,	_	,	_	_	41	P	_	_
44	Inc.	_	NNP	_	_	41	APPO	_	_
45	)	_	)	_	_	38	P	_	_
46	in	_	IN	_	_	18	VMOD	_	_
47	blocking	_	NN	_	_	48	NMOD	_	_
48	buffer	_	NN	_	_	46	PMOD	_	_
49	containing	_	VBG	_	_	48	APPO	_	_
50	3	_	CD	_	_	51	AMOD	_	_
51	%	_	NN	_	_	52	NMOD	_	_
52	milk	_	NN	_	_	49	VMOD	_	_
53	in	_	IN	_	_	49	VMOD	_	_
54	TBS	_	NNS	_	_	53	PMOD	_	_
55	Tween	_	NNP	_	_	54	NMOD	_	_
56	overnight	_	JJ	_	_	54	APPO	_	_
57	at	_	IN	_	_	56	AMOD	_	_
58	4degreesC	_	NN	_	_	57	PMOD	_	_
59	.	_	.	_	_	3	P	_	_
		
1	The	_	DT	_	_	2	NMOD	_	_
2	blots	_	NNS	_	_	3	VMOD	_	_
3	were	_	VBD	_	_	0	ROOT	_	_
4	developed	_	VBN	_	_	3	VC	_	_
5	using	_	VBG	_	_	4	VMOD	_	_
6	an	_	DT	_	_	10	NMOD	_	_
7	anti-rabbit	_	JJ	_	_	10	NMOD	_	_
8	IgG	_	NN	_	_	10	NMOD	_	_
9	HRP-labeled	_	JJ	_	_	10	NMOD	_	_
10	mAb	_	NN	_	_	5	VMOD	_	_
11	(	_	(	_	_	4	P	_	_
12	Cell	_	NN	_	_	14	NMOD	_	_
13	Signaling	_	NN	_	_	14	NMOD	_	_
14	Technology	_	NN	_	_	4	VMOD	_	_
15	)	_	)	_	_	4	P	_	_
16	and	_	CC	_	_	4	COORD	_	_
17	visualized	_	VBN	_	_	16	CONJ	_	_
18	with	_	IN	_	_	17	VMOD	_	_
19	a	_	DT	_	_	23	NMOD	_	_
20	LAS-1000	_	NN	_	_	23	NMOD	_	_
21	gel	_	NN	_	_	23	NMOD	_	_
22	documentation	_	NN	_	_	23	NMOD	_	_
23	system	_	NN	_	_	18	PMOD	_	_
24	(	_	(	_	_	25	P	_	_
25	Fujifilm	_	NNP	_	_	23	PRN	_	_
26	)	_	)	_	_	25	P	_	_
27	.	_	.	_	_	3	P	_	_
		
1	To	_	TO	_	_	0	ROOT	_	_
2	confirm	_	VB	_	_	1	IM	_	_
3	sample	_	NN	_	_	4	NMOD	_	_
4	loading	_	NN	_	_	2	VMOD	_	_
5	and	_	CC	_	_	1	COORD	_	_
6	transfer	_	NN	_	_	7	NMOD	_	_
7	membranes	_	NNS	_	_	5	CONJ	_	_
8	were	_	VBD	_	_	7	COORD	_	_
9	incubated	_	VBN	_	_	8	VC	_	_
10	in	_	IN	_	_	9	VMOD	_	_
11	stripping	_	JJ	_	_	12	NMOD	_	_
12	buffer	_	NN	_	_	10	PMOD	_	_
13	and	_	CC	_	_	9	COORD	_	_
14	reblocked	_	VBN	_	_	13	CONJ	_	_
15	for	_	IN	_	_	14	VMOD	_	_
16	1	_	CD	_	_	17	NMOD	_	_
17	h	_	NN	_	_	15	PMOD	_	_
18	and	_	CC	_	_	14	COORD	_	_
19	reprobed	_	VBN	_	_	18	CONJ	_	_
20	using	_	VBG	_	_	19	VMOD	_	_
21	anti-GAPDH	_	NN	_	_	20	VMOD	_	_
22	(	_	(	_	_	23	P	_	_
23	6C5	_	NN	_	_	21	PRN	_	_
24	;	_	:	_	_	23	P	_	_
25	Ambion	_	NN	_	_	23	APPO	_	_
26	)	_	)	_	_	23	P	_	_
27	and	_	CC	_	_	19	COORD	_	_
28	developed	_	VBN	_	_	27	CONJ	_	_
29	using	_	VBG	_	_	28	VMOD	_	_
30	an	_	DT	_	_	34	NMOD	_	_
31	anti-mouse	_	JJ	_	_	34	NMOD	_	_
32	IgG	_	NN	_	_	34	NMOD	_	_
33	HRP-labeled	_	JJ	_	_	34	NMOD	_	_
34	mAb	_	NN	_	_	29	VMOD	_	_
35	(	_	(	_	_	38	P	_	_
36	Cell	_	NN	_	_	38	NMOD	_	_
37	Signaling	_	NN	_	_	38	NMOD	_	_
38	Technology	_	NN	_	_	34	PRN	_	_
39	)	_	)	_	_	38	P	_	_
40	.	_	.	_	_	1	P	_	_
		
